Loading insider details...
Beta
Latest Form 4 (Jul 16, 2026): Exercise/Conversion of 16,250 GALT shares, $49.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 16,250 | $49.4K |
| Jun 30, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 2,037 | $4.5K |
| Jun 25, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 7,557 | $9.3K |
| May 28, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 568 | $698.64 |
| Jan 21, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 65,000 | n/a |
| Jan 6, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 60,000 | n/a |
| Jan 5, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 8,125 | $10.0K |
| Dec 19, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Sale | 4,479 | $31.5K |
| Nov 14, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Sale | 21,867 | $119.6K |
| Jan 27, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 65,000 | n/a |